GlaxoSmithKline: Insider AppointmentSix months ago, Andrew Witty, long-time CEO of Britains largest drug maker GlaxoSmithKline, announced he would retire in 2017. Now, GSK has named Emma Walmsley from inside the company as his successor. more ➔
Making a profitGerman molecular diagnostics specialist GNA Biosolutions GmbH has appointed Frank Krieg-Schneider as its Managing Director and CEO. Krieg-Schneider holds a PhD in molecular genetics from Mainz University … more ➔
Union builderSwedish Gyros Protein Technologies AB, which was formed in spring by merging nanoliter-scale immunoassay expert Gyros AB and peptide synthesis instrumentation and reagent provider Protein Technologies … more ➔
Bioelectric proGalvani Bioelectronics, the developer of bioelectronic medicines launched by GlaxoSmithKline and Alphabets life science play Verily (formerly Google Life Sciences) in early August, will have a bioelectronic … more ➔
Clinical development know-howFrench biopharma company Pharnext has appointed René Goedkoop as its new Chief Medical Officer. He joins the neurodegenerative disease specialist from Swiss Shogu Consulting SarL. more ➔
Immunotherapy pioneerMatthias Schroff, erstwhile CEO of Mologen, has taken over the helm of immunotherapy developer Vaximm AG. The Swiss-German company appointed him Chief Executive Officer in early September. more ➔
Overseas chiefSwedish clinical-stage biopharmaceutical company Aprea AB has named Christian Schade President and Chief Executive Officer. Before joining Aprea, Schade was CEO of US antiviral developer Novira Therapeutics, … more ➔
Vaccine proBrussels-based vaccine developer Univac has appointed a new CEO. In March, Stefano Malvolti joined Univac from Gavi, the Vaccine Alliance, where he was responsible for rolling out the vaccine development … more ➔
Pharma execFaron Pharmaceuticals has someone new to oversee its drug development strategy. In early May, the Turku-based clinical stage biopharma company appointed Matti Karvonen as its new Medical Director. … more ➔
Dab hand at financesUS- and UK-based genomics company Inivata has appointed Timothy Shannon as Chief Financial Officer. Shannon joins Inivata fom Baxano Surgical, where he held the position of CFO and treasurer. more ➔